Initial Treatment for Post-Viral Arthritis

First-Line Management

The European League Against Rheumatism recommends NSAIDs as the first-line treatment for post-viral arthritis at the minimum effective dose for the shortest time possible after evaluation of gastrointestinal, renal, and cardiovascular risks 1, 2
A trial of scheduled NSAIDs is appropriate for initial therapy, but should be brief due to potential adverse effects (gastritis, bruising) 4, 5
Intra-articular glucocorticoid injections should be considered for relief of localized joint inflammation, particularly for oligoarticular involvement 6
Early recognition and treatment is critical to prevent potential progression to chronic arthritis 6

If symptoms persist beyond 1 month of NSAID therapy, consider escalating treatment 2
For moderate pain with signs of inflammation limiting activities, consider oral prednisone 10-20 mg/day or equivalent 6
If using oral glucocorticoids, they should be limited to the lowest effective dose for the shortest duration possible (<6 months) 1, 2
For oligoarticular involvement that doesn't respond to NSAIDs, intra-articular steroid injections are particularly effective 6, 5

If arthritis persists despite NSAIDs and/or glucocorticoids, methotrexate should be considered as the anchor disease-modifying antirheumatic drug (DMARD) 1, 2
For severe pain with inflammation limiting self-care activities, consider temporary hold of activities and initiate oral prednisone 0.5-1 mg/kg 6
If no improvement after 2 weeks of glucocorticoid therapy, consider synthetic DMARDs such as methotrexate, leflunomide, hydroxychloroquine, or sulfasalazine 6
Referral to rheumatology is appropriate for patients with persistent symptoms beyond 4-6 weeks 6

Disease activity should be assessed at 1-3 month intervals until treatment target has been reached 3
Monitoring should include tender and swollen joint counts, patient and physician global assessments, ESR and CRP 3
Non-pharmacological interventions such as dynamic exercises and occupational therapy should be considered as adjuncts to drug treatment 3